Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Testis expressed transcript, Y-linked 17A (TTTY17A) is a Y chromosome-encoded long non-coding RNA (lncRNA) specifically expressed in human testis tissue. It does not encode a protein and is considered a non-coding RNA gene, as reflected by its alternative designations such as “non-protein coding RNA 140” and “NCRNA00140”. Molecular characterization indicates that it belongs to the large and functionally diverse family of long non-coding RNAs, which often function in gene expression regulation, chromatin organization, or testis-specific biology. There is no evidence that TTTY17A is a therapeutic target—it is neither a receptor, enzyme, transporter, nor a similar druggable target class. Its biological function, clinical significance, and interacting partners remain largely undefined, as is common for many annotated lncRNAs, particularly those specifically expressed in the testis and mapped to the Y chromosome. There are no known diseases linked to mutations or dysregulation of TTTY17A, and no biomarkers or small molecules are known to interact with it.
Not applicable; no drugs are reported to target this lncRNA
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Testis expressed transcript, Y-linked 17A (TTTY17A).